Tokyo, Oct. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063222) titled 'Anti-aging effects of ERALIUM cosmetics with nanoPDS containing NMN on skin: an open-label study' on Oct. 8.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - national university corporation Tokushima University

Condition: Condition - Healthy Japanese Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To verify the anti-aging effects of ERALIUM cosmetics with nanoPDS containing NMN on skin. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Duration: 8 weeks Test product: ERALIUM cosmetics with nanoPDS containing NMN and control cosmetics Administration: Once every morning, apply an appropriate amount of ERALIUM SpaceTime Gel Essence followed by ERALIUM SpaceTime Oil Serum to the left side of face, and apply an appropriate amount of the control products (lotion followed by serum) to the right side of face.

Eligibility: Age-lower limit - 40 years-old = Gender - Female Key inclusion criteria - 1. Japanese

2. Women

3. Individuals aged between 40 and 60

4. Healthy individuals

5. Individuals who have not used ERALIUM cosmetics with nanoPDS containing NMN

6. Individuals who are judged as eligible to participate in the study by the physician Key exclusion criteria - Individuals (who) 1.have factors on the evaluation site that may affect the results

2.have had cosmetic treatments on the evaluation site, or plan to have them during this study

3.have received special skincare treatments on the evaluation site within the past 4 weeks, or plan to receive them during this study

4.continuously use skin care products, cosmetics, quasi-drugs, or health foods that claim or emphasize effects or benefits that are similar to or related to the efficacy evaluated in this study on the evaluation site

5.have changed or started using new health supplements, basic skincare products, or sunscreen on the evaluation site within the past 4 weeks

6.have had excessive UV rays beyond daily life within the past 4 weeks, or plan to do during this study

7.are late-night shift workers or shift workers

8.receive treatment at medical institutions for the treatment or prevention of diseases or are determined to require treatment at the time of agreement to participate in this study

9.have a history of severe diseases: carbohydrate metabolism, lipid metabolism, liver function, kidney function, the heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system, or a history of psychiatric disorder

10.have a history of alcohol or drug dependence

11.have risk of developing allergies to cosmetics or foods

12.are pregnant, or lactating at the time of agreement to participate in this study, planning to become pregnant during this study

13.are pregnant, or lactating

14.have a history of allergy due to using cosmetics

15.have undergone cosmetic medical procedures that may affect the evaluation site

16.with inflammation or skin disease on the observation site

17.have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate another study during this study

18.are deemed unsuitable for participation in this study by the principal investigator Target Size - 20

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 10 Month 07 Day Date of IRB - 2026 Year 10 Month 07 Day Anticipated trial start date - 2026 Year 10 Month 08 Day Last follow-up date - 2026 Year 12 Month 25 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072363

Disclaimer: Curated by HT Syndication.